Vicarious Surgical Inc. RBOT

Company Overview

Vicarious Surgical Inc. is a medical technology company focused on the development of next-generation robotic surgical systems designed to enable minimally invasive procedures through a single incision. The company operates within the medical devices and surgical robotics industries, targeting hospitals and surgical centers seeking to improve patient outcomes, reduce invasiveness, and enhance surgeon capabilities. Its core offering is a proprietary robotic platform that combines human-like dexterity with advanced visualization, aiming to replicate the full range of motion of the human arm inside the body.

The company’s primary revenue driver is expected to be the future commercialization of the Vicarious Surgical System, along with recurring revenue from instruments, accessories, and service contracts. As of the most recent publicly available disclosures, the company has not yet generated material commercial revenue and remains in the pre-commercial and clinical validation stage. Founded in 2014, Vicarious Surgical evolved from an academic research initiative into a publicly traded company following its merger with a special purpose acquisition company in 2021, providing capital to advance regulatory approval, product development, and manufacturing readiness.